Lyme disease stakeholder scoping workshop

Similar documents
Lyme Disease Surveillance in Wisconsin Christopher Steward Division of Public Health Wisconsin Department of Health Services 04/10/2014

STATEMENT FOR MANAGING LYME DISEASE IN NOVA SCOTIA

LYME DISEASE Last revised May 30, 2012

Health Council of the Netherlands. A closer look at Lyme disease. The Hague: Health Council of the Netherlands, 2013; publication no. 2013/12.

Fatigue, persistence after Lyme borreliosis 196, 197 Francisella tularensis, see Tularemia

Infectious Diseases Expert Group (IDEG) Department of Health and Wellness. Statement for Managing Lyme Disease in Nova Scotia

Lyme disease conference

Announcements. Please mute your phones and DO NOT place us on hold. Press *6 to mute your phone.

LYME DISEASE: NEW OPTIONS FOR TREATMENT

Lyme Disease. By Farrah Jangda

Persistent pain: scope workshop discussions Date: 04/10/2017. How do we distinguish non-specific pain from discrete pain conditions?

Tick Talk: What s new in Lyme Disease. May 5 th, 2017 Cristina Baker, M.D., M.P.H.

A Patient s Guide to Lyme Disease

A Patient s Guide to Lyme Disease

Lyme disease Overview

patient group direction

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Technology appraisal guidance Published: 21 February 2018 nice.org.uk/guidance/ta507

Lyme disease Overview

Update on Lyme Disease Surveillance in Wisconsin for Providers and Laboratories

Not currently the time of year, but spring is around the corner. Seems to be in the news every other week. Task forces being formed.

PE1662/E Lyme Disease Action submission of 27 October 2017

National Institute for Health and Clinical Excellence

Peter J. Weina, PhD, MD, FACP, FIDSA. Colonel, Medical Corps, US Army Deputy Commander Walter Reed Army Institute of Research

Q fever. Lyme disease LDA Conference Anja Garritsen 1. Lyme Disease Diagnostics. Today s presentation

Addressing Tick Borne Diseases in Ireland. Dr. John Lambert - Professor of Medicine and Infectious Diseases, Mater Hospital & UCD School of Medicine

Title Protocol for Insect Bites Stings for Patients in MIUs and WICs

Lyme Disease, an Infectious Diseases Perspective

In February 2015, the Joint Committee on Vaccination and Immunisation (JCVI) *

Reflections on NICE Headache Guideline. Dr Kay Kennis GPwSI in Headache, Bradford

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA)

Seroprevalence of Babesia microti in Individuals with Lyme Disease. Sabino R. Curcio, M.S, MLS(ASCP)

(Would you like to include: <5mm, 5-10mm?)

July 27 th - 31 st Provisional Programme. Monday DiLo Cardiologist DiLo Cardiothoracic Surgeon DiLo Acute Physician

Lyme disease. Information for you. Follow us on Find us on Facebook at Visit our website:

Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses to Borrelia burgdorferi Years after Active Lyme Disease

Area Laboratory Service

First Afebrile Seizure

Botulinum toxin type A for the prevention of headaches in adults with chronic migraine

Working Group Practices and Composition

Lyme Disease. Abstract Lyme disease is a vector borne infection primarily transmitted by Ixodes ticks and. Special Issue

Lyme disease conference

Technology appraisal guidance Published: 24 January 2018 nice.org.uk/guidance/ta499

Technology appraisal guidance Published: 4 June 2015 nice.org.uk/guidance/ta340

Meningococcal Infections Management Procedure

LU:research Institutional Repository of Lund University

Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS.

Assessment and diagnosis of chronic fatigue syndrome myalgic encephalomyelitis

MP Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease. Related Policies None

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

WOMENCARE. Herpes. Source: PDR.net Page 1 of 8. A Healthy Woman is a Powerful Woman (407)

Botox for chronic migraine. Information for patients Neurology

Low back pain and sciatica in over 16s NICE quality standard

A summary of guidance related to viral rash in pregnancy

CEWT (Children s Epilepsy Workstream in Trent) Guidelines process.

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

SPEECH #3: INFORMATIVE SPEECH

STEVEN E. PHILLIPS, MD

Practitioner Mentorship

Supplementary Appendix

Kesia Backman 1 and Barbro H. Skogman 2,3*

Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta464

NICE: Single technology appraisal: Belimumab for the treatment of active auto-antibody systemic lupus erythematosus (April 2012)

The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis

My Case Study Solution

Guideline scope Neonatal parenteral nutrition

PROFESSOR DAME SALLY C DAVIES CHIEF MEDICAL OFFICER CHIEF SCIENTIFIC ADVISER

Technology appraisal guidance Published: 28 March 2018 nice.org.uk/guidance/ta516

Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza

NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding.

Lyme disease and Bell s palsy:

The Beginner's Guide to LYME DISEASE

Lyme Disease. 1. DISEASE REPORTING A. Purpose of Reporting and Surveillance

NO DISCLOSURES. Lyme Disease Convention and Controversies. Willie Burgdorfer, Ph.D. ( ) RM Lab in Hamilton, MT 1/20/2017

Smoking cessation interventions and services

We ll be our own lifesavers. We ll get the flu vaccine.

Ixekizumab for treating moderate to severe plaque psoriasis [ID904]

MR imaging findings in neuro-lyme disease.

Specialist care for chronic fatigue syndrome myalgic encephalomyelitis

29/10. Treatment (brand name, manufacturer): For the treatment of: Background: Rituximab (MabThera, Roche) SLE in adults (unlicensed)

General practitioner reported incidence of Lyme carditis in the Netherlands

Chickenpox Procedure. (IPC Policy Manual)

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

The cost-effectiveness of vaccination against Lyme disease Shadick N A, Liang M H, Phillips C B, Fossel K, Kuntz K M

5 Diagnosis. Timely diagnosis. Back to contents

Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta464

Information for people who use NHS services for bacterial meningitis and meningococcal septicaemia in children and young people

Coastal California. migrans rash at least 5 cm in diameter or specific musculoskeletal, in California identified 399 autochthonous cases of Lyme

Title: Public Health Reporting and National Notification for Lyme Disease

The Oxford AHSN Sepsis Pathway

Methotrexate for inflammatory bowel disease: what you need to know

NICE support for commissioning for urinary tract infection in infants, children and young people under 16

Lyme Disease Diagnosis and Treatment

Professional organisation statement template

CLINICAL COMMISSIONING GROUP PRIMARY CARE COMMITTEE EXECUTIVE SUMMARY

METHYLPHENIDATE AND ATOMOXETINE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND YOUNG PEOPLE

Transcription:

1.1 Who is the focus: Groups that will be covered: Adults and children with a suspected or confirmed diagnosis of Lyme disease 1.2. Settings All setting where NHS care The group suggested that the following groups might be split into different subgroups due to the difference in how they initially present with Lyme disease: People with more than one condition Pregnant women Children under 2 (neuro borrelia) People who are immunocompromised People who have previously had Lyme disease Congenital Lyme No comments Chronic/late - terms are not helpful. Suggested: post treatment Lyme disease syndrome. However people don't like the term syndrome Avoid using the term chronic Lyme Late Lyme can be meningitis, encephalitis, arthritis, chronic fatigue. Definitions are generally inconsistent. Other groups are those that respond to antibiotics/don't respond to antibiotics, immunosuppressed, pregnant women. People can be put into categories Suggestion to list main presenting symptoms then look at treatment approaches and what the criteria for different types of treatment are. No comments No comments No comments Page 1 of 8

is provided or commissioned 1.3 Key areas that will be covered Assessment [history and examination] Diagnosis [first line investigations and confirmatory tests] Management [treatment for early and late Lyme disease] Transmission Areas that will not be covered Management of confirmed non-borrelia diagnosis Management of a confirmed diagnosis of chronic fatigue syndrome Key areas that will be covered The group suggested that reevaluation might be added to this group, with GPs following up. Key areas that will not be covered The group agreed that if chronic fatigue syndrome was in this list then so should fibromyalgia, and other related NICE guidance on management No comments No comments 1.4 Economic aspects It was noted that as there are so many different investigations for Lyme disease, that healthcare professionals needed to be more No comments Page 2 of 8 No comments

definitive and confident, as there can be misdiagnosis with the general mind-set that Lyme disease is too rare. There is a lack of access to appropriate tests at clinical presentation, so this could be something to consider. 1.5 Key issues and questions Assessment In whom should Lyme disease be suspected? Which symptoms or clinical signs should lead to diagnostic testing to confirm or rule out Lyme disease? Diagnosis Which is the most test or combination of tests for diagnosing Lyme disease? Diagnosis The group thought the list of diagnostic tests were good and thorough but wondered whether they would differentiate between different species. They also asked whether the tests go through accreditation. The group agreed that definitions of newly-identified species should be included where possible, as this affects how the diagnostic tests can be interpreted. The group agreed that the four main species diagnostic accuracy of tests should be evaluated for were: Diagnosis The group wanted all available tests to be considered. Interpretation of test results and diagnosis is an important issue. Can Lyme disease be diagnosed without a positive test? There are cases where diagnostic tests are not needed (known tick bite and rash). Erythema migrans can appear differently to the classic bull s eye. The scope could include tests and other investigations (e.g. nerve conduction studies). Test limitations Diagnosis The group noted it would be important to look at the sensitivity and specificity of each test and there will be a need for consensus from the guideline committee to determine the gold standard. Clinicians need to give guidance on sensitivity and specificity of each test available on NHS or others and for named tests there may be a need to refer to infectious diseases colleagues. There are permutations and combinations of 20 pathogens for Lyme disease. What selection can Page 3 of 8

Management What is the best management strategy when there is a definite tick bite without symptoms? What is the most treatment for early localised Lyme disease with an erythema migrans? What is the most treatment for early localised Lyme disease without erythema migrans? What is the most treatment for early disseminated Lyme disease without erythema migrans? What is the most treatment for chronic Lyme disease of any Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii, Borellia burgdorferi sensu stricto. The group also discussed that tests reporting a negative ELISA will not be send off by the labs, so this also needs clarification. The group agreed that there needed to be definitions of what constitutes core Lyme disease, so then it can be prioritised. Scope needs separate definitions section, and the group were not sure what early localised presentation without a rash would actually be. The group suggested that late Lyme disease would be no treatment in 4-6 months. desirable to have a question to define prophylactic treatment. Suggest looking at the International Lyme and Associated Diseases Society guideline for prevention and prophylactic treatment. accuracy/interpretation may be different in special groups such as pregnant women and immunocompromised patients. Tests should be carried out in the context of a patient s medical history. There is an overreliance on testing a combination of symptoms, history, diagnostic tests and other investigations should inform a diagnosis. Clinical history will guide tests e.g. holidays to specific areas. GPs need to know which questions to ask. If there are classic symptoms but negative test results, other available tests could be considered. It is important to identify clinical situations for tests. The starting point is defining clinical groups. Management The group noted a question: when someone has a definite tick bite change the outcome? The subdivisions of Lyme disease are under diagnosed e.g. if a person is immunosuppressed what is the effect of Lyme on this person, or do tests on this group of people manifest in different presentations? A question was asked: In pregnant women can Lyme disease be transmitted to the baby? A diagnostic test for each patient with Lyme disease is not required if there are clinical circumstances e.g. if there is a migrans rash present. With clinical presentations groups who need testing should be clear. and the epidemiology leading to algorithm in assessment should be clear. In the UK NHS tests are only for 2 strains. Some people go and get tested elsewhere e.g. Germany/abroad if negative result in UK lab tests. The UK needs more Page 4 of 8

manifestation: In people who have not received treatment for Lyme disease? In people whose symptoms recur after a treatment course is finished? What is the most management strategy if symptoms persist after a treatment course is finished? Transmission Can Lyme disease be transmitted from person to person? Transmission The group suggested that there might be another section to the transmission section regarding transmission through mosquitos and horseflies as there has been new evidence surrounding this. without symptoms, should prophylaxis be given? Suggestion to remove the term localised, and change to with localising symptoms. Localised means affecting one area e.g. erythema migrans or facial palsy. Disseminated means symptoms move from one area to another e.g. erythema migrans then headache. Early disseminated Lyme disease with erythema migrans highlighted as missing from the clinical categories. Subjective symptoms like general headache are much harder to assess/diagnose. Cognitive symptoms are a separate category they may be more subtle and more gradual. Different treatment may be recommended for different clinical categories (e.g. cognitive, cardiac, neurological). bands. There are different strains and there are 20 genomes of Borrelia. In overseas tests e.g. Germany they look at 20 bands. However bands are not a differential diagnosis and there are limitations of tests. There needs to be scoping of a wide range of tests and which bands considered to capture? How long after symptoms should tests be done? Antibodies can take several weeks to manifest. Tests useful to some however some people are falling through the net. Clinical scores are used in private practice but not in the NHS. We need to look at the cumulative evidence in different tests Management A question was raised: What are the indications for intravenous (IV) or circumstances IV therapy or oral is given? There are randomised Page 5 of 8

Severity may influence treatment duration. Early Lyme can be defined as less than 6 months from tick bite/feeling unwell (most commonly tick bite or rash). Late can be defined as more than 6 months from tick bite / feeling unwell. (Neurologic and cardiac symptoms usually occur between 4 and 8 weeks.) There is uncertainty in identifying Lyme in approximately 1 in 5 patients; may be higher for children as the rash may appear on the scalp where it is not visible (ticks may bite higher on children as they are lower to the ground). Time between tick bite and symptoms is variable. Suggestion to change chronic to late. Often patients see infectious disease specialists having already been to other specialists. Page 6 of 8 controlled trials investigating IV vs. oral Usual agents are Doxycycline/amoxicillin/cefuroxime. What about 2 agents single or in combination? What are the presentations for management? Know contraindications treat all infections patient survey 60% had Lyme disease infection.

Possible additional question noted: What is the best management strategy for patients with nonclassic symptoms with positive/negative tests? Main outcomes Quality of life Clinical symptoms / cure Adverse events Resource use Diagnostic test accuracy No comments No comments No comments Guideline committee composition Consultant in infectious diseases (adult) Consultant in infectious disease (paediatric) General practitioner x 2 Adult general physician (or general/rheumatology) General paediatrician Adult neurologist The group suggested the following should be considered for the GC composition: Bioethical considerations specialist Immunologist as co-opted Dermatologist as co-opted One GP who has experience of Lyme disease and One GP who hasn t May not need psychologist; could be changed to neuro-psychiatrist (could be co-opted expert). Dermatology nurse GPs and general physicians are trained in endocrinology, gastroenterology etc., so don't need additional specialists. Immunology expertise is needed if it is not covered in the current group. TB infection nurse? Primary/community nurse advert Adult General Physicians do they exist? No paediatric neurologist No psychiatrist/psychologist GP one from rural area one from non-rural Immunologist? Page 7 of 8

Paediatric neurologist Microbiologist Rheumatologist Psychiatrist/psychologist Practice nurse / primary care nurse or pharmacist with experience of identifying infection in the community Lay member x 2 may cover. For consideration as expert advisers (TBC) Chronic fatigue syndrome expert Alternative medicine practitioner Cardiologist Other issues None Suggestion to change the title from Lyme disease to Lyme borreliosis (in line with other European guidelines). None Page 8 of 8